Showing results (41-50 of 93) with videos related to
Sort By:
Pageof 10
Oncotarget|October 6, 2017
Decreased WWOX expression promotes angiogenesis in osteosarcomaJia Wen, Zongchao Xu, Jiazhen Li, et al.Journal of Chromatography. A|August 25, 2009
Application of Snyder-Dolan classification scheme to the selection of "orthogonal" columns for fast screening of illicit drugs and impurity profiling of pharmaceuticals--I. Isocratic elutionWenzhe Fan, Yu Zhang, Peter W Carr, et al.The Oncologist|October 9, 2015
Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective AnalysisYingqiang Zhang, Wenzhe Fan, Yu Wang, et al.Journal of Cancer Research and Clinical Oncology|December 13, 2018
Evaluation of the effects of intra-arterial chemotherapy combined with intravesical chemotherapy against intravesical chemotherapy alone after transurethral resection of bladder tumor in T1-staged Grade 3 bladder cancerBin Huang, Hua Wang, Hao Lin, et al.Cancer Management and Research|February 14, 2022
Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACEHongyu Wang, Guixiong Zhang, Wenzhe Fan, et al.The Oncologist|June 29, 2019
Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial ChemoembolizationYanqin Wu, Wenzhe Fan, Miao Xue, et al.Biology Direct|June 16, 2026
Analysis and validation of abnormal signaling pathways and immune cell infiltration characteristics in digestive system cancers based on peroxisome-related genesJie Wen, Zhihui Wang, Shuyang Luo, et al.Journal of Cancer Research and Clinical Oncology|March 23, 2019
Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancerFan Lian, Wenchuan Chen, Yiming Liu, et al.The Journal of International Medical Research|May 28, 2021
Cyclin B1 acts as a tumor microenvironment-related cancer promoter and prognostic biomarker in hepatocellular carcinomaYangming Hou, Xin Wang, Junwei Wang, et al.Hepatology (Baltimore, Md.)|February 15, 2024
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 studyMeiyan Zhu, Zelong Liu, Shuling Chen, et al.Pageof 10